Neoadjuvant Danburstotug (IMC-001) therapy in gastric, esophageal, and hepatocellular carcinoma: the NeoChance phase II study.
Saved in:
| Title: | Neoadjuvant Danburstotug (IMC-001) therapy in gastric, esophageal, and hepatocellular carcinoma: the NeoChance phase II study. |
|---|---|
| Authors: | Bang YH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kang D; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea.; BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea., Lee S; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea.; BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea., Kim S; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea.; BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea., Jeon I; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea.; BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea., Park E; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea.; BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea., Choi J; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea.; BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea., Song GW; Department of Liver Transplantation and Hepatobiliary Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Yoo MW; Department of Stomach Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Song JS; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Song IH; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim YH; Department of Thoracic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim HR; Department of Thoracic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Song HJ; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim DH; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Choi KD; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lee JH; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Ahn JY; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Shim JH; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lee D; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Choi J; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim JE; Biomedical Research Center, Asan Medical Center, Seoul, Republic of Korea., Kim SY; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea., Bae DJ; PrismCDX Co., Ltd., Hwaseong-si, Gyeonggi-do, Republic of Korea., Park SR; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. srpark@amc.seoul.kr. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2026 Jul 03. Date of Electronic Publication: 2026 Jul 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
